Delayed graft function after renal transplantation

W W Pfaff1, R J Howard, P R Patton

  • 1Department of Surgery, University of Florida College of Medicine, Gainesville 32610-0286, USA.

Transplantation
|February 11, 1998
PubMed

Insights

Donor factors like age and cause of death are linked to delayed graft function (DGF) in kidney transplants. However, these factors do not predict long-term graft survival, suggesting other variables are crucial.

Area of Science:

  • Nephrology
  • Transplantation immunology
  • Organ donation

Background:

  • Delayed graft function (DGF) is strongly associated with reduced graft survival (GS) in cadaveric renal transplants.
  • Identifying donor characteristics predicting adverse outcomes is critical for improving transplant success.

Purpose of the Study:

  • To identify specific donor characteristics that predict the occurrence of delayed graft function (DGF) in renal transplant recipients.
  • To investigate the relationship between donor factors, DGF, and subsequent graft survival.

Main Methods:

  • Retrospective review of 509 organ donors and 586 renal transplant recipients between 1990 and 1995.
  • Analysis of donor demographics, cause of death, ischemia times, and transplant outcomes.
  • Statistical analysis including multiple logistic regression to identify significant predictors.

Main Results:

  • Donor age, cause of death, and ischemic times (cold and anastomotic) significantly correlated with DGF frequency.
  • Factors such as procurement year, donor gender, race, and hypotension did not impact DGF rates.
  • While DGF significantly reduced one-year graft survival (76.6% vs. 93.2%), the identified donor factors did not correlate with 1-year GS.

Conclusions:

  • Increased ischemia, donor age, and specific causes of death are associated with DGF in kidney transplantation.
  • Despite the link between DGF and reduced graft survival, the studied donor factors do not predict long-term GS.
  • This suggests that unidentified variables play a significant role in early graft outcomes after renal transplantation.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...